Sign inGet started

Hallett David

Insider CIK 2006495 · RXRX Chief Scientific Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
RXRX RECURSION PHARMACEUTICALS, F Tax w/h2026-08-172026-08-1826,657$3.16 $84.2K1,043,837SEC↗
RXRX RECURSION PHARMACEUTICALS, F Tax w/h2026-08-172026-08-1826,657$3.16 $84.2K1,043,837SEC↗
RXRX RECURSION PHARMACEUTICALS, F Tax w/h2026-05-152026-05-1926,657$3.04 $81.0K1,070,494SEC↗
RXRX RECURSION PHARMACEUTICALS, F Tax w/h2026-02-172026-02-1911,908$3.49 $41.6K1,097,151SEC↗
RXRX RECURSION PHARMACEUTICALS, F Tax w/h2026-02-062026-02-1011,400$3.98 $45.4K1,109,059SEC↗
RXRX RECURSION PHARMACEUTICALS, A Award2026-02-062026-02-10502,064— $01,096,205SEC↗
RXRX RECURSION PHARMACEUTICALS, A Award2026-02-062026-02-1024,254— $01,120,459SEC↗